Disease/Infection News

RSS

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections.

25 Oct 2019

Scientists make breakthrough in the hunt for new C. diff vaccine

Scientists have made a breakthrough in the hunt for a new vaccine for killer hospital bug Clostridioides difficile (C. diff).

25 Oct 2019

UAB physicians encourage everyone to get a flu shot between October and early November

The change of season in October and November brings in crisp, fall weather for the majority of the United States. Many begin to look toward the holiday season to come, but few think about the impending cold weather and subsequent sickness that pops up when winter arrives.

25 Oct 2019

Most of the world unprepared for next epidemic or pandemic, GHS Index shows

No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.

25 Oct 2019

Flu antibody could be a key to better treatments for severe flu disease

Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

24 Oct 2019

Optimal implementation of existing, new interventions essential to end HIV pandemic

Optimal implementation of existing HIV prevention and treatment tools and continued development of new interventions are essential to ending the HIV pandemic, National Institutes of Health experts write in a commentary Clinical Infectious Diseases.

24 Oct 2019

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Universal influenza vaccine developed at Cornell is set for human clinical trials

A universal influenza vaccine with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.

24 Oct 2019

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell.

24 Oct 2019

GHS Index: Not a single country fully prepared to handle epidemic or pandemic

A new Global Health Security Index released today, the first comprehensive assessment and benchmarking of health security and related capabilities across 195 countries, suggests that not a single country in the world is fully prepared to handle an epidemic or pandemic.

24 Oct 2019

Vaccine for Lassa fever set to enter clinical testing in humans

There is currently no vaccine for the Lassa arenavirus, which causes Lassa fever. This hemorrhagic fever, endemic in West Africa, infects up to 300,000 people each year.

24 Oct 2019

Scientists find new strains of human adenovirus in Singapore

Human adenovirus (HAdV) infections in Singapore and Malaysia have caused severe respiratory disease among children and adults in recent years, but scientists still don't know whether these outbreaks are due to new or re-emerging virus strains.

24 Oct 2019

Cooperative research center at LLNL aims to develop vaccines for chlamydia

A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory.

24 Oct 2019

Emory researchers awarded NIAID contract to develop better drug against influenza

With the flu killing an average of 20,000 people annually in the United States and posing the larger threat of global pandemics, Emory University's strides in influenza research carry the hope of saving lives here and abroad.

23 Oct 2019

UAB researchers awarded grant to study a vaccine for gonorrhea

University of Alabama at Birmingham researchers have been awarded a three-year contract with a total potential amount of $10 million to study the efficacy of the vaccine Bexsero - already licensed to prevent meningitis - in protecting vulnerable populations from infection with the bacteria that causes gonorrhea.

23 Oct 2019

E. coli superbug spreading by poor toilet hygiene, not through food

A new study published in The Lancet Infectious Diseases on October 22, 2019, says that one common superbug that causes more than 5,000 cases of food poisoning in England every year is spread not through contaminated food but through contaminated toilet surfaces.

23 Oct 2019

New collaboration aims to develop gene-based cures for sickle cell disease and HIV

The National Institutes of Health plans to invest at least $100 million over the next four years toward an audacious goal: develop affordable, gene-based cures for sickle cell disease and HIV.

23 Oct 2019

New $30M contract signed to accelerate TB vaccine development across the country

Tuberculosis (TB) is the number-one cause of death from an infectious disease in the world: In 2017, the most recent data available, 10 million people developed TB and 1.6 million died.

23 Oct 2019

Anti-arthritis drug can stop tuberculosis bacillus from infecting blood stem cells

Immunologist Johan Van Weyenbergh (KU Leuven) and his Belgian-Brazilian colleagues have shown that a drug used to fight arthritis also stops the process that allows the tuberculosis bacillus to infect and hijack blood stem cells.

23 Oct 2019

Researchers assess accuracy of lateral flow urine LAM test in detecting TB in HIV-positive people

Tuberculosis (TB) causes more deaths in people living with HIV than any other disease, with more than 300,000 deaths in 2017. When detected, early TB can be treated effectively; however, people with advanced HIV are at high risk of death, often without knowing they have TB.

22 Oct 2019

Disease/Infection News

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

Scientists make breakthrough in the hunt for new C. diff vaccine

UAB physicians encourage everyone to get a flu shot between October and early November

Most of the world unprepared for next epidemic or pandemic, GHS Index shows

Flu antibody could be a key to better treatments for severe flu disease

Optimal implementation of existing, new interventions essential to end HIV pandemic

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

Universal influenza vaccine developed at Cornell is set for human clinical trials

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

GHS Index: Not a single country fully prepared to handle epidemic or pandemic

Vaccine for Lassa fever set to enter clinical testing in humans

Scientists find new strains of human adenovirus in Singapore

Cooperative research center at LLNL aims to develop vaccines for chlamydia

Emory researchers awarded NIAID contract to develop better drug against influenza

UAB researchers awarded grant to study a vaccine for gonorrhea

E. coli superbug spreading by poor toilet hygiene, not through food

New collaboration aims to develop gene-based cures for sickle cell disease and HIV

New $30M contract signed to accelerate TB vaccine development across the country

Anti-arthritis drug can stop tuberculosis bacillus from infecting blood stem cells

Researchers assess accuracy of lateral flow urine LAM test in detecting TB in HIV-positive people

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News